Litigation Details for ADAPT PHARMA OPERATIONS LIMITED v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2018)
✉ Email this page to a colleague
ADAPT PHARMA OPERATIONS LIMITED v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2018)
| Docket | ⤷ Try a Trial | Date Filed | 2018-04-09 |
| Court | District Court, D. New Jersey | Date Terminated | 2022-07-27 |
| Cause | 15:1126 Patent Infringement | Assigned To | Brian R. Martinotti |
| Jury Demand | None | Referred To | Joseph A. Dickson |
| Parties | OPIANT PHARMACEUTICALS, INC. | ||
| Patents | 7,977,376; 8,063,004; 9,211,253; 9,468,747; 9,480,644; 9,561,177; 9,707,226 | ||
| Attorneys | CHARLES MICHAEL LIZZA | ||
| Firms | Gibbons P.C. | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in ADAPT PHARMA OPERATIONS LIMITED v. TEVA PHARMACEUTICALS USA, INC.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Biologic Drugs cited in ADAPT PHARMA OPERATIONS LIMITED v. TEVA PHARMACEUTICALS USA, INC.
The biologic drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for ADAPT PHARMA OPERATIONS LIMITED v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-04-09 | 1 | 7,977,376 B2 7/2011 Singh et al .............…United States Patent Nos. 9,480,644 (the “’644 patent”) and 9,707,226 (the “’226 patent”) (collectively… 1. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C… The Patent-in-suit 12. On November 1, 2016, the United States Patent and Trademark… the ’644 patent, entitled, “Nasal Drug Products and Methods of Their Use.” The ’644 patent is assigned | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
